Clearside Biomedical's Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® for Suprachoroidal Delivery
Stock Information for Clearside Biomedical Inc.
Loading
Please wait while we load your information from QuoteMedia.